ABT-267

Known as: ABT 267, ABT267 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2015
02420132015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
INTRODUCTION The global prevalence of chronic hepatitis C virus (HCV) is estimated to be 80 - 115 million and currently viremic… (More)
Is this relevant?
2015
2015
UNLABELLED Approximately 2 million Japanese individuals are infected with hepatitis C virus and are at risk for cirrhosis, end… (More)
  • table 1
  • table 2
  • table 3
  • table 2
  • table 3
Is this relevant?
2015
2015
BACKGROUND Opportunities to treat infection with hepatitis C virus (HCV) are evolving rapidly. From the introduction of… (More)
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND Interferon-containing regimens for the treatment of hepatitis C virus (HCV) infection are associated with increased… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND The interferon-free combination of the protease inhibitor ABT-450 with ritonavir (ABT-450/r) and the NS5A inhibitor… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2014
2014
We describe here N-phenylpyrrolidine-based inhibitors of HCV NS5A with excellent potency, metabolic stability, and… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND An interferon-free combination of the protease inhibitor ABT-450 with ritonavir (ABT-450/r), the nonnucleoside… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Review
2014
Review
2014
INTRODUCTION Chronic hepatitis C infection is a global disease with 160 million people infected worldwide. Until recently… (More)
Is this relevant?
2014
2014
BACKGROUND: The interferon-free combination of the protease inhibitor ABT-450 with ritonavir (ABT-450/r) and the NS5A inhibitor… (More)
  • figure 1
Is this relevant?
2014
2014
Opportunities to treat infection with hepatitis C virus (HCV) are evolving rapidly. From the introduction of interferona… (More)
Is this relevant?